This is an old revision of this page, as edited by Kpjas (talk | contribs) at 08:33, 28 July 2004. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 08:33, 28 July 2004 by Kpjas (talk | contribs)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)Beta blockers or beta-adrenergic blocking agents are certain drugs used to treat a variety of cardiovascular conditions and some other diseases. They block the action of epinephrine and norepinephrine on beta-type adrenergic receptors in the body (primarily in the heart, peripheral blood vessels, bronchi, pancreas, and liver). The hormones and neurotransmitters stimulate the sympathetic nervous system by acting on these receptors.
There are two types of beta receptors: beta 1 receptors located mainly in the heart, and beta 2 receptors located all over the body, but mainly in the lungs, muscles and arterioles.
If epinephrine acts on beta 1 receptors, the heart rate and the blood pressure increase, and the heart itself requires more oxygen. Drugs that block these beta 1 receptors therefore have the opposite effect: they lower the heart rate and blood pressure and are useful when the heart itself is deprived of oxygen. They are often prescribed after heart attacks. In addition, beta blockers prevent the release of renin, which is a hormone produced by the kidneys which leads to constriction of blood vessels.
Drugs that block beta 2 receptors generally have a relaxing effect and are prescribed for anxiety, migraine and alcohol withdrawal syndrome, among others. Many beta blockers affect both type 1 and type 2 receptors.
Non-selective beta blockers should not be used in patients with asthma or any reactive airway disease. Doing so can block the effects of Beta-2 agonists, such as salbutamol.
| Beta blockers (C07) | |
|---|---|
| β, non-selective | |
| β1-selective | |
| β2-selective | |
| α1- + β-selective | |
| |